• About us
• Contact

Advertisement

Organisation › Details

Nestlé (Group)

Nestlé is the world's largest food and beverage company. It is present in 187 countries around the world, and its 290,000 employees are committed to Nestlé's purpose of enhancing the quality of life and contributing to a healthier future. Nestlé offers a wide portfolio of products and services for people and their pets throughout their lives. Its more than 2,000 brands range from global icons like Nescafé or Nespresso to local favourites like Ninho. Company performance is driven by its Nutrition, Health and Wellness strategy. Nestlé is based in the Swiss town of Vevey where it was founded more than 150 years ago. *

 

	Start	1990-02-01 existent
	Industry	foods & beverages
	Person	Bulcke, Paul (Nestlé 201402 CEO)
	Person 2	Martello, Wan Ling (Nestlé 201402 CFO)
	Region	Vevey VD
	Country	Switzerland
	Street	55 Avenue Nestlé
	City	1800 Vevey VD
	Tel	+41-21-924-2111
		Address record changed: 2020-12-02
Basic data	Employees	J: more than 100,0 (2020-12-15)
	Currency	CHF
	Annual sales	92,158,000,000 (sales (2013) 2013-12-31)
		* Document for »About Section«: ECBF Management GmbH. (12/15/20). "Press Release: The European Circular Bioeconomy Fund Has Raised €175 Million to Foster Sustainable Innovations". Luxembourg.
		Record changed: 2024-12-29

Advertisement

More documents for Nestlé (Group)

• [1] Seres Therapeutics, Inc.. (6/6/24). "Press Release: Seres Therapeutics Enters into Memorandum of Understanding for Vowst Asset Sale to Nestlé Health Science". Cambridge, MA....
• [2] Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024"....
• [3] Seres Therapeutics, Inc.. (4/26/23). "Press Release: Seres Therapeutics and Nestlé Health Science Announce FDA Approval of Vowst (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial...
• [4] Enterome S.A.. (7/18/22). "Press Release: Enterome Signs Major Strategic R&D Collaboration with Nestlé Health Science to Develop and Commercialize New AllerMimics and EndoMimics Immunotherapies for Food Allergies and Inflammatory Bowel Disease". Paris....
• [5] Seres Therapeutics, Inc.. (7/1/21). "Press Release: Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement". Cambridge, MA & Lausanne....
• [6] ECBF Management GmbH. (12/15/20). "Press Release: The European Circular Bioeconomy Fund Welcomes Nestlé as an Investor to Accelerate Sustainable Innovation in Europe". Luxembourg....
• [7] Aimmune Therapeutics, Inc.. (8/31/20). "Press Release: Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science". Brisbane, CA....
• [8] Seres Therapeutics, Inc.. (8/17/20). "Press Release: Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock". Cambridge, MA....
• [9] Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA....
• [10] Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.